XLO - US Stocks Flat; Initial Jobless Claims Fall To 210000 | Benzinga
U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday.
Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell 0.08% to 16,385.80. The S&P 500 also rose, gaining, 0.04% to 5,250.38.
Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'
Leading and Lagging Sectors
Real estate shares jumped by 0.7% on Thursday.
In trading on Thursday, information technology shares fell by 0.2%.
Top Headline
U.S. initial jobless claims fell by 2,000 to 210,000 in the week ending March 23, compared to market estimates of 215,000.
Equities Trading UP
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares shot up 435% to $24.91 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million.
Shares of Xilio Therapeutics, Inc. (NASDAQ: XLO) got a boost, surging 154% to $1.62 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing.